Requires health insurance coverage for early-stage kidney disease screening without cost sharing.
Introduced First Reading Assembly Referred to AFI
Email me when A 4915 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track A 4915. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs all health‑insurance contracts and plans in the state to pay for a physician‑ordered eGFR blood test or urine albumin‑creatinine ratio when the doctor deems it medically necessary, with no cost‑sharing charges. It applies to individual, group, hospital‑service, and state‑run health‑benefit contracts, as well as high‑deductible and catastrophic plans, as long as federal law permits. The goal is to catch chronic kidney disease early, a condition that has been rising sharply in New Jersey.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about A 4915
3 free questions a day, no accountHistory
- Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Sponsors
- Stewart, Kenyatta · sponsor
- Kearney, Vincent M.
- Speight, Shanique
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when A 4915 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track A 4915 freeOr ask your AI assistant about A 4915 directly:
Add to Claude, ChatGPT or Cursor